The online pipeline is undergoing construction. Please refer to this PowerPoint for most up-to-date pipeline.

Hit-to-Lead


TB Alliance, Rutgers University
TB Alliance, Calibr
SPRINT-TB (National University of Singapore)
UPenn,TB Alliance
SPRINT-TB (National University of Singapore)
Lilly TB Drug Discovery Initiative
TB Alliance, Sanofi
University of Illinois at Chicago, Myongji University
Lilly TB Drug Discovery Initative
University of Illinois at Chicago
GlaxoSmithKline, TB Alliance
Texas A&M University
Colorado State University

Lead Optmization


TB Alliance, Sanofi
TB Alliance, Calibr
Kanury Rao, Sundeep Duggar
SPRINT-TB (National University of Singapore)
SPRINT-TB (National University of Singapore)
SPRINT-TB (National University of Singapore)
GlaxoSmithKline, Global Alliance for TB Drug Development
TB Alliance/Yonsei University
Sequella
TB Alliance
Sanofi , TB Alliance
UNESP/School of Pharmaceutical Sciences
TB Alliance, University of Auckland, Janssen
GlaxoSmithKline
Anacor Pharmaceuticals, GlaxoSmithKline

Pre-Clinical (Non-GLP)


TB Alliance, Sanofi
St Jude Children's Research Hospital, University of Tennessee Health Science Center, Colorado State University, University of Zurich, Microbiotix
Institute of Materia Medica
Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan, Lilly TB Drug Discovery Initiative, NIAID, IDRI, Lilly, YourEncore